4188.TWO · AMCAD
Taiwan · RS rating 73 · As of 2026-10-08
| Price | 13.95 TWD |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 73 / 60 / 93 / 35 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 30 / 34 / 34 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | -12.5% |
| Sales growth Q/Q | +5.2% |
| Distance from 52-week high | +15.4% |
| Market cap (USD) | $28.0M |